Item 7.01 Regulation FD Disclosure.
On September 15, 2022, Jupiter Wellness, Inc. (the “Company”) issued a letter to
its shareholders (the “Shareholder Letter”) highlighting the Company’s revenue
results for the second quarter of 2022 and certain research and development
efforts. A copy of the letter to stockholders is attached hereto as Exhibit
99.1, and is incorporated herein by reference. In addition, the Company issued a
press release, attached hereto as Exhibit 99.2, which describes the Shareholder
Letter and includes a link to the Shareholder Letter on the Company’s web site.
Copies of the shareholder letter and press release are attached as Exhibits 99.1
and 99.2 to this Current Report on Form 8-K and are incorporated herein by
reference. The information in this Item 7.01 of this Form 8-K, including Exhibit
99.1 attached hereto, is being furnished and shall not be deemed “filed” for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), nor shall it be deemed incorporated by reference in any filing
of ours under the Securities Act of 1933, as amended, or the Exchange Act,
whether made before or after the date hereof, except as shall be expressly set
forth by specific reference to this Form 8-K in such filing.
This filing and attached exhibits includes “forward-looking statements.” All
statements other than statements of historical facts included or incorporated
herein may constitute forward-looking statements. Actual results could vary
significantly from those expressed or implied in such statements and are subject
to a number of risks and uncertainties. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we can
give no assurance that such expectations will prove to be correct. The
forward-looking statements involve risks and uncertainties that affect our
operations and financial performance. We do not undertake any duty to update any
forward-looking statement except as required by law.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description 99.1 Shareholder Letter dated September 15, 2022 99.2 Press Release dated September 15, 2022 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) 2
© Edgar Online, source Glimpses